Ancora Advisors LLC Takes $1.41 Million Position in Corteva, Inc. $CTVA

Key Points

• Ancora Advisors acquired 16,690 shares of Corteva worth approximately $1.41 million during the second quarter. Institutional investors collectively own 81.54% of the company, with BlackRock holding a new position valued at roughly $4.56 billion.
• Corteva reported quarterly EPS of $2.30, beating estimates of $2.24, while revenue of $6.38 billion fell short of the $6.60 billion consensus and declined 1.2% year over year. The company expects fiscal 2026 EPS of $3.60–$3.80.
• The company declared a quarterly dividend of $0.18, equivalent to $0.72 annually and a 0.9% yield. Analysts maintain a “Moderate Buy” consensus rating with an average price target of $91.50, above the reported $82.27 share price.

Ancora Advisors LLC bought a new stake in shares of Corteva, Inc. (NYSE:CTVA - Free Report) during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund bought 16,690 shares of the company's stock, valued at approximately $1,413,000.

A number of other institutional investors and hedge funds have also bought and sold shares of the stock. BlackRock Inc. purchased a new position in Corteva in the second quarter worth $4,560,180,000. Harris Associates L P increased its position in shares of Corteva by 168.1% during the 4th quarter. Harris Associates L P now owns 17,026,221 shares of the company's stock valued at $1,141,268,000 after purchasing an additional 10,675,052 shares during the last quarter. Norges Bank bought a new stake in shares of Corteva during the 4th quarter worth $504,001,000. Legal & General Group Plc bought a new stake in shares of Corteva during the 2nd quarter worth $482,836,000. Finally, Royal Bank of Canada boosted its holdings in shares of Corteva by 202.1% in the 1st quarter. Royal Bank of Canada now owns 7,458,624 shares of the company's stock worth $624,362,000 after buying an additional 4,989,371 shares during the last quarter. 81.54% of the stock is owned by hedge funds and other institutional investors.

Corteva Stock Performance

NYSE:CTVA opened at $82.27 on Friday. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.10 and a current ratio of 1.52. Corteva, Inc. has a 52-week low of $60.53 and a 52-week high of $90.97. The firm has a market cap of $54.89 billion, a price-to-earnings ratio of 54.48, a PEG ratio of 2.54 and a beta of 0.57. The business's fifty day moving average is $82.58 and its 200 day moving average is $80.52.

Corteva (NYSE:CTVA - Get Free Report) last issued its earnings results on Thursday, July 30th. The company reported $2.30 EPS for the quarter, topping the consensus estimate of $2.24 by $0.06. The business had revenue of $6.38 billion during the quarter, compared to the consensus estimate of $6.60 billion. Corteva had a return on equity of 10.18% and a net margin of 5.66%.The firm's revenue was down 1.2% compared to the same quarter last year. During the same quarter last year, the company earned $2.20 EPS. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. Research analysts predict that Corteva, Inc. will post 3.72 EPS for the current year.

Corteva Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 15th. Stockholders of record on Tuesday, September 1st will be given a $0.18 dividend. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.9%. The ex-dividend date is Tuesday, September 1st. Corteva's dividend payout ratio (DPR) is 47.68%.

Analyst Ratings Changes

Several brokerages have commented on CTVA. Mizuho lifted their price objective on shares of Corteva from $96.00 to $97.00 and gave the stock an "outperform" rating in a research report on Tuesday, July 14th. BMO Capital Markets increased their target price on shares of Corteva from $95.00 to $100.00 and gave the company an "outperform" rating in a research report on Monday, August 3rd. Deutsche Bank Aktiengesellschaft restated a "buy" rating and set a $101.00 price target on shares of Corteva in a research note on Monday, August 3rd. Barclays lifted their price target on shares of Corteva from $84.00 to $91.00 and gave the stock an "overweight" rating in a report on Thursday, June 11th. Finally, CICC Research increased their price objective on Corteva from $80.00 to $93.00 and gave the company an "outperform" rating in a report on Wednesday, May 13th. Fourteen analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company's stock. According to data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $91.50.

About Corteva

Corteva, Inc NYSE: CTVA is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva's operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source